Free Trial

Handelsbanken Fonder AB Acquires 4,600 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Axon Enterprise logo with Aerospace background

Handelsbanken Fonder AB lifted its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 12.3% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 41,902 shares of the biotechnology company's stock after acquiring an additional 4,600 shares during the period. Handelsbanken Fonder AB owned 0.05% of Axon Enterprise worth $22,038,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Venturi Wealth Management LLC lifted its position in Axon Enterprise by 2.7% in the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock valued at $477,000 after purchasing an additional 21 shares during the period. Beacon Pointe Advisors LLC increased its position in shares of Axon Enterprise by 2.6% in the 4th quarter. Beacon Pointe Advisors LLC now owns 864 shares of the biotechnology company's stock worth $513,000 after purchasing an additional 22 shares during the last quarter. Transcend Capital Advisors LLC grew its position in shares of Axon Enterprise by 3.6% during the 4th quarter. Transcend Capital Advisors LLC now owns 726 shares of the biotechnology company's stock valued at $431,000 after buying an additional 25 shares during the last quarter. Fielder Capital Group LLC boosted its stake in Axon Enterprise by 2.2% during the 4th quarter. Fielder Capital Group LLC now owns 1,176 shares of the biotechnology company's stock valued at $699,000 after purchasing an additional 25 shares during the period. Finally, Interchange Capital Partners LLC lifted its stake in shares of Axon Enterprise by 1.9% in the 4th quarter. Interchange Capital Partners LLC now owns 1,310 shares of the biotechnology company's stock worth $779,000 after acquiring an additional 25 shares during the period. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts recently commented on the stock. Northcoast Research lowered shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. Bank of America raised their price objective on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a report on Wednesday, June 4th. Needham & Company LLC lifted their price target on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a report on Thursday, May 8th. The Goldman Sachs Group lifted their price objective on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research note on Wednesday, May 14th. Finally, Craig Hallum lowered shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and ten have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $699.55.

View Our Latest Analysis on AXON

Insider Buying and Selling at Axon Enterprise

In related news, Director Michael Garnreiter sold 87 shares of the firm's stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $760.00, for a total value of $66,120.00. Following the transaction, the director now owns 24,653 shares of the company's stock, valued at approximately $18,736,280. This trade represents a 0.35% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction dated Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the sale, the chief executive officer now owns 3,063,982 shares of the company's stock, valued at approximately $1,657,583,622.18. This trade represents a 0.33% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 43,969 shares of company stock worth $29,909,594. Insiders own 4.40% of the company's stock.

Axon Enterprise Stock Up 0.7%

Shares of AXON stock traded up $5.43 during trading hours on Friday, reaching $780.63. The company had a trading volume of 358,906 shares, compared to its average volume of 719,761. Axon Enterprise, Inc. has a twelve month low of $279.02 and a twelve month high of $806.64. The stock's fifty day simple moving average is $669.47 and its 200 day simple moving average is $621.44. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company has a market capitalization of $60.77 billion, a P/E ratio of 201.71, a price-to-earnings-growth ratio of 5.17 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.34 by $0.07. The company had revenue of $603.63 million for the quarter, compared to analysts' expectations of $585.67 million. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The firm's revenue for the quarter was up 31.3% on a year-over-year basis. During the same period last year, the firm earned $1.15 EPS. As a group, sell-side analysts expect that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Stories

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Should You Invest $1,000 in Axon Enterprise Right Now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Bought This Stock at the Bottom—Will You Miss It?
The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines